Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 25
- Registration Number
- NCT00004077
- Locations
- 🇬🇧
Velindre Hospital, Cardiff, Wales, United Kingdom
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Raghu Nandan, M.D., Inc
- Registration Number
- NCT00005825
- Locations
- 🇺🇸
Rajendra Prasad M.D., Inc., Lakewood, California, United States
Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 482
- Registration Number
- NCT00003027
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 743
- Registration Number
- NCT00047008
- Locations
- 🇺🇸
McKay-Dee Hospital Center, Ogden, Utah, United States
🇺🇸Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States
🇺🇸Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 21
- Registration Number
- NCT00005850
- Locations
- 🇺🇸
Memorial Regional Hospital Comprehensive Cancer Center, Hollywood, Florida, United States
🇺🇸Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center, West Palm Beach, Florida, United States
🇺🇸Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States
Chemotherapy in Treating Children With Liver Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Societe Internationale d'Oncologie Pediatrique
- Target Recruit Count
- 260
- Registration Number
- NCT00003912
- Locations
- 🇮🇹
Azienda Ospedaliera di Padova, Padova, Italy
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 600
- Registration Number
- NCT00003159
- Locations
- 🇬🇧
Medical Research Council Clinical Trials Unit, London, England, United Kingdom
🇬🇧Royal Marsden NHS Foundation Trust - Surrey, Sutton, England, United Kingdom
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 659
- Registration Number
- NCT00006011
- Locations
- 🇺🇸
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 432
- Registration Number
- NCT00006237
- Locations
- 🇺🇸
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain, Connecticut, United States
🇺🇸Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States
🇺🇸Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Federation Francophone de Cancerologie Digestive
- Target Recruit Count
- 195
- Registration Number
- NCT00047112
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇧🇪Hopital Universitaire Erasme, Brussels, Belgium
🇧🇪Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.